Answers are grounded in this paper and cite their sources.
STUDY QUESTION Are reproductive factors associated with the risk of incident osteoporosis in postmenopausal women? SUMMARY ANSWER Reproductive factors reflecting longer lifetime endogenous estrogen exposure, particularly a longer reproductive span, were associated with a lower risk of incident osteoporosis, whereas factors reflecting shorter or interrupted exposure were associated with a higher risk. WHAT IS KNOWN ALREADY Estrogen deficiency is a key driver of postmenopausal bone loss, and reproductive history influences cumulative lifetime estrogen exposure. Previous studies have linked individual reproductive factors to bone mineral density or fracture risk, but the direct relationship between multiple reproductive factors and incident osteoporosis in a large population-based cohort has not been fully characterized. STUDY DESIGN, SIZE, DURATION This nationwide retrospective cohort study used Korean National Health Insurance Service data. A total of 5,071,643 postmenopausal women aged 40–79 years who participated in health and cancer screening between 2009 and 2012 were initially identified. After exclusions, women who developed osteoporosis during follow-up were matched 1:1 by propensity score to women who did not, yielding a matched cohort of 2,147,384 women followed until 31 December 2022. The median follow-up duration was 110 months. PARTICIPANTS/MATERIALS, SETTING, METHODS The study population comprised postmenopausal Korean women aged 40–79 years drawn from a nationwide administrative and screening database. Reproductive history variables were obtained from standardized self-administered questionnaires and included age at menarche, age at menopause, reproductive span, parity, cumulative breastfeeding duration, oral contraceptive (OC) use, and menopausal hormone therapy (MHT) use. Incident osteoporosis was defined by the presence of both a bone mineral density testing procedure code and a diagnosis code for osteoporosis. Women who developed osteoporosis were matched 1:1 to those who did not on a propensity score derived from demographic, anthropometric, metabolic, comorbidity and lifestyle covariates, excluding reproductive and hormonal variables. In the matched cohort, stratified Cox proportional hazards models included only the mutually adjusted reproductive and hormonal variables, as the matching covariates were already balanced. Sensitivity analyses in the unmatched cohort were additionally adjusted for all covariates. MAIN RESULTS AND THE ROLE OF CHANCE In the matched cohort, menarche before age 13 was associated with a lower risk of osteoporosis than menarche at 13–16 years (hazard ratio (HR) 0.91, 99.3% confidence interval (CI) 0.88–0.93), whereas menarche at age 17 years or later was associated with a higher risk (HR 1.11, 99.3% CI 1.10–1.12). Menopause at age 55 years or older was associated with a lower risk (HR 0.96, 99.3% CI 0.96–0.97), whereas menopause at 40–44 years was associated with a higher risk (HR 1.10, 99.3% CI 1.08–1.11), compared with menopause at 50–54 years. A reproductive span of 40 years or longer was associated with a lower risk than a span of less than 30 years (HR 0.82, 99.3% CI 0.81–0.83), showing a dose-response pattern. Before matching, the crude cumulative incidence of osteoporosis during follow-up was 25.1%, 32.1%, and 40.0% in women with menarche before 13 years, at 13–16 years, and at 17 years or later, respectively, and 39.8% and 36.1% in women with a reproductive span of less than 30 years and 40 years or longer, respectively. Primiparity was associated with a lower risk than nulliparity (HR 0.92, 99.3% CI 0.90–0.94). In contrast, breastfeeding for 12 months or longer was associated with a higher risk than never breastfeeding (HR 1.13, 99.3% CI 1.12–1.15). OC use of any duration was associated with a modestly higher risk than never use (HR 1.04 for both duration categories; all P < 0.001). MHT use of any duration was also associated with a higher risk than no use (HR 1.11, 1.10, and 1.08 for <2, 2–4, and ≥5 years, respectively; all P < 0.001). Unlike the OC finding, this MHT finding contrasts with the established protective effect of MHT on bone and most likely reflects confounding by indication, as women with earlier menopause or greater baseline skeletal risk are more likely to receive treatment. Trends across reproductive categories were statistically significant, and sensitivity analyses showed similar directional findings. LIMITATIONS, REASONS FOR CAUTION This study was retrospective and observational, so causality cannot be inferred. Reproductive exposures were self-reported and may be affected by recall bias, and residual confounding from unmeasured variables such as calcium intake, vitamin D status, long-term physical activity, and genetic predisposition is possible. Osteoporosis was identified using administrative data rather than direct review of bone mineral density values, and the outcome definition included both primary and secondary osteoporosis. Information on hormone therapy formulation, dose, route, timing and indication was also unavailable. The results may not be fully generalizable beyond Korean postmenopausal women. WIDER IMPLICATIONS OF THE FINDINGS Reproductive history may provide clinically useful information for osteoporosis risk stratification in postmenopausal women. Reproductive span may serve as an integrated marker of overall endocrine and metabolic health, rather than of estrogen exposure alone, and may help identify women who could benefit from earlier screening or preventive intervention. FUNDING This study received no funding. DISCLOSURES The authors declare that they have no competing interests. TRIAL REGISTRATION NUMBER N/A.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: